+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diagnostic Landscape in Cancer Research

  • Book

  • March 2025
  • Elsevier Science and Technology
  • ID: 6006268
Diagnostic Landscape in Cancer Landscape examines the combined impact of prevention, diagnosis, and treatment of cancer. With a strong focus on the status, challenges, and prospects of diagnostic tools and technology, the book also examines the clinical translation-related knowledge and prognosis of different organ related cancers. In 22 chapters, the book describes current and new diagnostic tools in twenty different cancers and explores how innovations in the cancer diagnostic space could make cancer screening and early detection more straightforward.

This book is a timely and valuable resource for health professionals, scientists, researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.

Table of Contents

1. Diagnostic Landscape in Liver cancer: current and new
2. Diagnostic Landscape in Pancrea cancer : current and new
3. Diagnostic Landscape in in Heart cancer : current and new
4. Diagnostic Landscape in Bone cancer : current and new
5. Diagnostic Landscape in Spleen cancer: current and new
6. Diagnostic Landscape in ENT cancer : current and new
7. Diagnostic Landscape in Brain/CNS cancer: current and new
8. Diagnostic Landscape in Skin cancer: current and new
9. Diagnostic Landscape in Lung cancer: current and new
10. Diagnostic Landscape in Thorax cancer: current and new
11. Diagnostic Landscape in Thyroid cancer: current and new
12. Diagnostic Landscape in Kidney-adrenal: current and new
13. Diagnostic Landscape in Urinary track: current and new
14. Diagnostic Landscape in Breast: current and new
15. Diagnostic Landscape in Colorectal: current and new
16. Diagnostic Landscape in Blood cancer: current and new
17. Diagnostic Landscape in Prostate cancer: current and new
18. Diagnostic Landscape in Ovarian cancer: current and new
19. Diagnostic Landscape in Stomach and intestinal cancer: current and new
20. Diagnostic Landscape in Plura and peritonium Cancer: current and new
21. Diagnostic power of cfDNA for early detection and treatment monitoring of oral squamous cell carcinoma
22. Diagnostic trends in ocular cancer

Authors

Ranjita Shegokar Postdoctoral Researcher, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, Germany.

Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)

Yashwant Pathak Professor and Associate Dean, Faculty Affairs, College of Pharmacy, University of South Florida, Tampa, USA. Yashwant Pathak is a Professor and Associate Dean for faculty affairs at the Taneja College of Pharmacy at the University of South Florida, Tampa, USA. Prof. Pathak is also an Adjunct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia. His area of research is in health care education, nanotechnology, drug delivery systems, and nutraceuticals.